Daiichi Sankyo

This study looked at how well the blood thinner edoxaban works and its safety in people aged 80 and older with a type of irregular heartbeat called atrial fibrillation. Atrial fibrillation raises the risk of stroke, especially in older adults. The study followed over 1,200 patien…

This study tested a drug called trastuzumab deruxtecan in 152 people with a specific type of advanced lung cancer (HER2-mutated) that had gotten worse after standard treatment. The main goal was to see if the drug could shrink tumors. The study was completed and measured how many…

This study looked at how well a cholesterol-lowering drug called bempedoic acid works in Taiwanese adults with high cholesterol. About 180 people took the drug for 12 weeks to see if it safely lowered their bad cholesterol (LDL-C) and helped them reach their cholesterol goals. Th…

This study tested a new drug, trastuzumab deruxtecan, against standard treatments in 608 people with advanced HER2-positive breast cancer that had already been treated with T-DM1. The goal was to see if the new drug could slow cancer growth or improve survival. Results help docto…

This study tested a drug called trastuzumab deruxtecan (T-DXd) in 122 people with advanced colorectal cancer that has high levels of a protein called HER2. The goal was to see if the drug could shrink tumors. The approach uses an antibody-drug conjugate to deliver chemotherapy di…

This study tested a new drug called DS-1062a in 137 adults with advanced or spreading non-small cell lung cancer that has certain gene changes. Participants had already tried targeted therapy and platinum chemotherapy without success. The main goal was to see if the drug could sh…

This study looked at whether a single pill containing three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and rosuvastatin) works the same as taking them separately. It involved 58 healthy adults aged 18 to 60. The goal was to check if the combination pill is absorbe…

This study checked if a new single pill containing three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and atorvastatin) works the same in the body as taking those three drugs separately. 58 healthy adults aged 18-60 each received both the combo pill and the separate…

This study analyzed data from 1,415 patients with a common type of advanced breast cancer (HR-positive, HER2-negative) whose first treatment stopped working. Researchers looked at how long patients lived without their cancer getting worse and overall survival after starting a sec…

This study looked at medical records from 509 adults in Taiwan to find out how often a protein called HER2 IHC 3+ appears in advanced endometrial, ovarian, and cervical cancers. The goal was to better understand these cancers and help guide future treatment options. No new treatm…

This study tested whether a single pill containing three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and atorvastatin) works the same as taking them separately. It involved 58 healthy adults aged 18 to 60. The goal was to see if the combination pill is absorbed sim…

This study looked at whether a single pill containing three cholesterol-lowering drugs (bempedoic acid, ezetimibe, and rosuvastatin) works the same as taking them separately. It involved 58 healthy adults aged 18 to 60. The goal was to measure how the drugs are absorbed and proce…